Events - Exclusive Event CoverageAnbio Biotechnology Reveals Advanced Diagnostics at Medlab ME 2024

Anbio Biotechnology Reveals Advanced Diagnostics at Medlab ME 2024

Medlab Middle East is one of the largest international exhibitions for the medical laboratory industry in the world.

Must Read

Dubai, UAE — Anbio Biotechnology, a globally recognized diagnostic device and assay company, is set to make a significant impact at Medlab Middle East 2024 in Dubai, scheduled from February 5 to 8, 2024. Renowned as one of the largest international exhibitions for the medical laboratory industry globally, Medlab Middle East provides an ideal platform for Anbio to showcase its innovative In Vitro Diagnostics (IVD) products.

Strategic Collaborations and Regional Empowerment

Anbio is eager to establish collaborations with local entities during the event, aiming to bring cutting-edge IVD products to the Middle East. Also, This strategic move underscores the company’s commitment to advancing healthcare solutions in the region.

Showcasing Advanced Diagnostic Innovations

At Medlab Middle East 2024, Anbio will showcase its latest diagnostic solutions, including:

1. Anbio FIA Solution: The comprehensive Anbio Fluorescence Immunoassay (FIA) Solution includes four types of analyzers, catering to various needs from portable handheld to bench-top sizes. With 78 available assays, it enables the detection of a wide range of analytes, including hormones, cancer markers, cardiac markers, drugs of abuse, inflammation, and infectious diseases.

2. Anbio CLIA Solution: Unveiling the ADL i1910 Chemiluminescence Immunoassay analyzer, a fully automated, high-throughput CLIA analyzer supporting both qualitative and quantitative testing with 50 CE-marked assays.

3. Anbio Dry-Chemistry Solution: Highlighting the SHA-100 Dry-Chemistry Analyzer, a compact, portable device supporting real-time testing and providing quantitative detection results for 18 test items.

4. Anbio Lamp Solution: Introducing the LAMP Solution, a diagnostic technique amplifying and detecting specific DNA or RNA sequences. Moreover, This innovative solution offers miniaturized analyzers for fast, sensitive, and specific results in detecting infectious diseases, genetic disorders, and foodborne pathogens.

Furthermore, Anbio Biotechnology invites attendees to explore its extensive POCT solutions, covering RT-PCR, Colloidal Gold, and advanced manufacturing capabilities. Meet them at Booth #Z1, G30 at the Dubai World Trade Center from February 5 to 8, 2024, to witness the future of diagnostics. Additionally, Anbio eagerly anticipates engaging with healthcare professionals and industry partners at this esteemed medical laboratory exhibition.

Readers Also Read: Medlab Middle East 2024: Shaping the Future of Healthcare with AI Integration

- Advertisement -


Professor Kirsty Le Doare Recognized in Top 5 Finalists for Prestigious MRC Millennium Medal

July 2024- Professor Kirsty Le Doare from St George's Institute for Infection and Immunity was shortlisted in the top...
- Advertisement -